Lerna Biopharma is a preclinical stage biopharmaceutical company developing RNA therapeutics for patients with liver diseases.
Investors 1
| Date | Name | Website |
| 27.05.2024 | EVX Ventur... | evx.ventur... |
Mentions in press and media 1
| Date | Title | Description |
| 06.11.2023 | Lerna Bio unveils its first-in-class solution to combat liver failure | SINGAPORE, CAMBRIDGE, Mass. and SHANGHAI, Nov. 6, 2023 /PRNewswire/ -- Lerna Biopharma Pte. Ltd (Lerna Bio) proudly announces the unveiling of its pioneering liver regeneration drug candidate, LR1, at The Liver Meeting in Boston organized b... |